Evidence level: C
上一篇把「打折划不划算」的判决全压在一个从未被估过的比例 π 上。把这张曲面翻开来算,会发现:π 在这里的分量小到几乎可以忽略,真正在推判决的是另一个量。
正文
一、把公式拆开,看 π 站在哪儿
「打折划算」的条件是 π 超过临界值 π*。这个 π* 没有闭式,但拆开来源后形式很简单:打折的功效增益记 ΔP,多付的假阳性记 Δα,则
π* = k·Δα / (k·Δα + ΔP)
k 是「一次假阳性」相对于「一次真检出」的代价比。用上一篇表内数值反解:ρ=0.5 时 ΔP=20.57 个百分点、Δα=4.44 个百分点,取 k=1 得 0.1775,文中报 0.178;ρ 从 0.2 到 0.9 五点逐一核对,最大偏差 0.0005。公式和表都没错。
问题在于这三个量里只有一个被认真对待过:ΔP 和 Δα 是定积分、算得准;而 k 和 π 都是拍出来的,k 甚至从未被提起。
二、π 不是分布参数,是尾概率
π 定义为「被比较的两份判读里真有差的比例」,听起来像总体参数,其实取决于你把多小的差算作「有差」。
设真实差值服从尺度为 s 的半正态(以独立标准误为单位)。取 s=0.5——典型差异只有半个标准误,判读研究里很现实——把「算有差」的门槛从 0.01 挪到 0.30 个标准误,π 就从 0.984 掉到 0.549。同一份数据、同一个分布,只因刻度线右移,π 掉了一半。 它不是能被估计的参数,而是必须连分辨率一起声明的导出量——而文献里两个都没报过。
三、就算去估,它和「差异多大」也分不开
用 spike-and-slab 混合模型直接数 π:模拟 40 个比较,真值 π=0.25、差异尺度 1.5 个标准误。极大似然给出 π=0.60、尺度 1.35,两个数都离真值很远。剖面似然更说明问题——尺度在 0.2 到 4.0 上扫、每个 π 取最优,对数似然下降不到 2 的区间覆盖 π 从 0.10 到 0.75。这一整条脊上,数据分不出哪个更合理。 重复 200 次,π 的估计均值 0.42、标准差 0.28,三成次数直接顶到搜索上界。
原因是「少量真差、每个都很大」与「很多真差、每个都很小」产生几乎相同的观测分布。要拆开必须先知道其中一个——而它恰是要估的那个。
四、最反直觉的一步:π 根本推不动判决
到这里结论似乎是「π 估不出,规则不能用」。但把整张曲面翻开来算,方向整个反了。
π* 的跨度确实吓人,从 0.051 到 0.990 近二十倍,可绝大部分落在没人会走的地方。取硬下界:只要分辨率不超过 0.30 个标准误,任何差异分布形状下 π 都不低于 0.549。在这个现实带内,ρ 从 0.20 到 0.95、z 从 0.5 到 3.0 的 832 个格点上,π 能推翻「打折」判决的只有 51 格,占 6%,且百分之百落在 z≥2.5 的反弹区;扣掉这块,624 个格点里一格都没有。π 取 0.55 还是 0.99,判决不同的格点只有 5.9%。对照:同样格点上把 ρ 从 0.3 变到 0.9,判决翻转 21%,是 π 的将近四倍。
因为 π* 在会做判决的整片区域里都低于 0.2,而现实的 π 高于 0.5。门槛在地板上,判决在房顶上,中间隔着一整个楼层。 真要翻案得让 π 掉到 0.05,那意味着二十个比较里只有一个真有差——这种研究本就不该谈打折。
五、真正在推判决的是那个没人问过的代价比
回到第一节的式子。取 ρ=0.5,把 k 从 0.25 挪到 10(前者「假阳性很轻」、后者「极重」),π* 从 0.051 变到 0.679,跨度 13 倍。同一行数据上,π 只挪动 5.9% 的格点,k 能把整片翻过来。
k 是什么?「一次误判相对于一次真检出值多少」,纯临床判断,数据里没有它的位置。净收益框架的原始文献说得很清楚:这个交换率必须由人指定,可以靠一个简单问题问出来——「为了找到一个真病人,最多愿让几个健康人做不必要的检查」——但答案主观,所以要把一整段合理取值都画成曲线看,不能由数据自证。
这条规则的真正支点,不在被反复担心的 π 上,而在从未被写出来的 k 上。 上一篇把 π 当软肋,是看错了位置。
π 仍有用途,但用途不同:它决定「赚多少」,不决定「赚不赚」。ρ=0.5、z=1.0 时每 100 次比较的净增正确判定:π=0.10 时 −1.94 次(净亏),0.25 时 +1.81 次,0.50 时 +8.06 次,0.80 时 +15.57 次。同一个「该打折」判决,收益能从亏两次到赚十五次。
六、这条线上现有研究的状态
必须说清:上面全是方法学推演,不是实证结论,而支撑它的经验基础薄得需要直说。
中医五脏辨证作为分组标签,信度本身处于未裁决的冲突。一项研究直接报告:中医师之间诊断一致性在开放人群中「低」,作者用「令人担忧」形容。同系列另一篇则指出问题可能出在统计工具——偶然校正类系数在低基率、多类别场合会被严重惩罚,建议改用对基率不敏感者;且有研究显示经问卷化诊断与培训可明显改善。两边都有理,也都没能推翻对方。放射影像领域的系统评价给了另一侧面:观察者间变异研究样本量普遍偏小且无依据,多数报了一致性系数,而这些系数常常与研究结论对不上。
至于「被判可辨的比较里真有差的比例」,方法学与临床文献都没有任何一篇报过。不是检索不全,是这个量从未被当成需要报告的东西。
L1 网络状态:E-060 标签前提 — conflict(未裁决)。原文摘录:「中医医师间诊断一致性在开放人群中『低(low)』,作者称为『令人担忧』(PMID 30383398);同系列第二篇指出偶然校正一致性统计常被误用、建议 Gwet AC2(PMID 31730403 / 31634000 / 31730404);但训练可改善(PMID 19538100)」→ 冲突双方:低一致性实测量 — 对 — 统计工具误用致低估、且训练可改善。该边指向「标签信度」,非「π 的可估性」,本文不据此边任一方作结论。
证据与局限
已验证:① π* 的闭式结构为 k·Δα/(k·Δα+ΔP),用表内五行数值反解最大偏差 0.0005;② π 是尾概率而非分布参数,门槛从 0.01 挪到 0.30 个标准误(s=0.5)可使 π 从 0.984 降至 0.549,属恒等式性质;③ π 与差异尺度在 spike-and-slab 下联合不可识别,剖面似然脊上 ΔlogL<2 覆盖 π∈[0.10,0.75];④ 在 π≥0.549 现实带内,832 个格点中 π 能推翻判决的仅 51 格且全在 z≥2.5,扣除后为 0/624;⑤ k 从 0.25 到 10 可使 π* 跨度 13 倍,判决翻转能力远超 π。
部分验证:① 格点统计依赖双线性插值,原表仅 6×4 节点,插值误差未量化;② 「π≥0.549」的推导假定差值服从半正态,若重尾(少数极大差异 + 多数微小差异)下界会下移;③ 定量换算用 k=1,k≠1 时数值需缩放,但定性结论不变;④ 不可识别结论在正态 slab 下成立,换重尾 slab 后脊形变、宽度未必收窄。
待验证:① 真实研究里 π 落在哪个量级全无数据,本文论断皆为理论下界非实测;② 分辨率该由谁定、定在哪,没有任何规范,而它直接决定 π;③ k 在判读研究语境下该取多少从未被讨论,而本文证明它比 π 重要得多;④ 「方法学与临床验证两类研究的 π 结构不同」无法用现有文献检验,因为两类都不报 π。
相关阅读
证据等级: C
参考文献: PMID 36123642, PMID 26810254, PMID 17099194, PMID 18177782, PMID 37399082, PMID 34062626, PMID 28626349, PMID 30383398, PMID 31730403, PMID 19538100, PMID 16483120
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
The decision on whether to discount or not actually fails to drive the judgment; what truly drives it is the cost ratio that has never been asked about.
Evidence level: C
In the previous article, the decision of whether discounting is cost-effective was entirely pressed onto a ratio π that had never been estimated. Unfolding this surface for calculation reveals: the weight of π here is so small it is almost negligible; what truly drives the decision is another quantity.
Main Text
I. Unpacking the Formula to See Where π Stands
The condition for “discounting is cost-effective” is that π exceeds the critical threshold π*. This π* has no closed form, but after unpacking its source, the structure is simple: let ΔP denote the efficacy gain from discounting and Δα denote the false positives incurred by paying more; then
π* = k·Δα / (k·Δα + ΔP)
where k is the cost ratio of “one false positive” relative to “one true detection.” Working backwards using the numerical values in the previous table: when ρ=0.5, ΔP=20.57 percentage points and Δα=4.44 percentage points; taking k=1 yields 0.1775, while the article reports 0.178; checking ρ from 0.2 to 0.9 at five points shows a maximum deviation of 0.0005. The formula and the table are both correct.
The problem lies in these three quantities: only one is taken seriously. ΔP and Δα are definite integrals, calculated precisely; whereas k and π are both ad hoc, with k never even mentioned.
II. π Is Not a Distribution Parameter, It Is a Tail Probability
π is defined as “the proportion of true differences among the two sets of readings being compared,” which sounds like a population parameter, but in fact it depends on how small a difference you count as “a difference.”
Suppose the true difference follows a half-normal distribution with scale s (in units of independent standard error). Taking s=0.5—typical differences amount to half a standard error, which is very realistic in reading studies—moving the threshold for “counting as different” from 0.01 to 0.30 standard errors causes π to drop from 0.984 to 0.549. The same data, the same distribution, yet because the scale line shifts right, π drops by half. It is not an estimable parameter; it is a derived quantity that must be declared together with the resolution—and neither has ever been reported in the literature.
III. Even If We Estimate It, It Is Inseparable from “How Large the Difference Is”
Using a spike-and-slab mixture model to directly count π: simulate 40 comparisons, true π=0.25, difference scale 1.5 standard errors. Maximum likelihood gives π=0.60 and scale 1.35, both far from the true values. Profile likelihood makes this even clearer—sweeping the scale from 0.2 to 4.0 and taking optimal π at each point, the log-likelihood drops by less than 2 over the interval covering π from 0.10 to 0.75. Along this entire ridge, the data cannot distinguish which is more reasonable. Repeating 200 times, the estimated mean of π is 0.42 with standard deviation 0.28; in one-third of cases it hits the upper bound of the search space.
The reason is that “few true differences, each large” and “many true differences, each small” produce nearly identical observed distributions. To disentangle them, one must know one of them beforehand—and that is precisely the quantity we wish to estimate.
IV. The Most Counterintuitive Step: π Cannot Drive the Decision at All
Up to here, the conclusion seems to be “π cannot be estimated, so the rule cannot be used.” But unfolding the entire surface for calculation reverses the direction entirely.
The span of π* is indeed startling, from 0.051 to 0.990—nearly twentyfold—but the vast majority falls in regions nobody would ever go to. Taking the hard lower bound: as long as resolution does not exceed 0.30 standard errors, under any difference distribution shape π never drops below 0.549. Within this realistic band, across the 832 grid points where ρ ranges from 0.20 to 0.95 and z from 0.5 to 3.0, π can overturn the “discounting” decision at only 51 grid points, accounting for 6%, and all of them fall entirely within the rebound zone where z≥2.5; after removing this region, none of the 624 remaining grid points can overturn it. Whether π is taken as 0.55 or 0.99, only 5.9% of the grid points yield different decisions. In contrast: on the same grid points, changing ρ from 0.3 to 0.9 flips the decision 21%, which is nearly four times what π does.
Because π* stays below 0.2 across the entire region where decisions are actually made, while the realistic π exceeds 0.5, the threshold lies on the floor, the decision lies on the ceiling, with an entire floor in between. To overturn the verdict would require π to drop to 0.05, meaning only one out of twenty comparisons truly differs—a study that should not even discuss discounting.
V. What Truly Drives the Decision Is That Cost Ratio Nobody Has Asked About
Returning to the formula in Section I. Taking ρ=0.5, moving k from 0.25 to 10 (the former implies “false positives are light,” the latter “extremely heavy”), π* shifts from 0.051 to 0.679—a span of 13 times. On the same row of data, π only shifts 5.9% of the grid points, whereas k can flip the entire landscape.
What is k? “How many times worse is one misjudgment compared to one true detection?” This is pure clinical judgment; there is no place for it in the data. The original literature on the net-gain framework states clearly: this exchange rate must be specified by humans, and can be elicited via a simple question—”To find one true patient, how many healthy people are you willing to subject to unnecessary testing?”—but the answer is subjective, so one must draw a curve over the entire range of reasonable values and cannot let the data speak for itself.
The true pivot of this rule lies not on π, which is repeatedly worried about, but on k, which has never been written down. In the previous article, treating π as the weak link was looking at the wrong place.
π still has use, but its role is different: it determines “how much to gain,” not “whether to gain.” For ρ=0.5 and z=1.0, the net increase in correct judgments per 100 comparisons is: −1.94 when π=0.10 (net loss), +1.81 when π=0.25, +8.06 when π=0.50, and +15.57 when π=0.80. The same “should discount” decision can yield gains ranging from losing twice to gaining fifteen times.
VI. The Current State of Research on This Line
It must be made clear: all the above are methodological derivations, not empirical conclusions, and the empirical foundation supporting them is so thin it needs to be stated outright.
The traditional consensus on TCM five-organ differentiation as grouping labels remains unresolved; reliability itself is in an undecided conflict. One study directly reports: among practitioners, diagnostic consistency in the open population is “low,” with authors describing it as “concerning.” Another paper in the same series points out that the problem may lie in statistical tools—coefficient of agreement corrected for chance is severely penalized under low base rates and multi-class settings, suggesting switching to measures insensitive to base rate; furthermore, studies show that questionnaire-based diagnosis and training can significantly improve it. Both sides have merit, yet neither has overturned the other. A systematic review in radiology provides another perspective: observer variation studies generally have undersized samples without justification, most report consistency coefficients, yet these coefficients often do not match the study conclusions.
As for “the proportion of true differences among comparisons deemed distinguishable,” neither methodology nor clinical literature has ever reported it. This is not due to incomplete searching; this quantity has never been regarded as something needing reporting.
L1 Network Status: E-060 label premise — conflict (undecided). Original excerpt: “Consistency among TCM practitioners in the open population is ‘low,’ described by authors as ‘concerning’ (PMID 30383398); the second paper in the same series indicates that chance-corrected agreement statistics are often misused and recommends Gwet AC2 (PMID 31730403 / 31634000 / 31730404); however, training can improve it (PMID 19538100).” → The two conflicting sides: low consistency measured directly — yes; statistical tools misused leading to underestimation, and training can improve. This side points to “label reliability,” not “estimability of π”; this article does not draw conclusions based on either side.
Evidence and Limitations
Verified: ① The closed-form structure of π* is k·Δα/(k·Δα+ΔP); back-solving with five numerical values from the table yields a maximum deviation of 0.0005; ② π is a tail probability, not a distribution parameter; shifting the threshold from 0.01 to 0.30 standard errors (s=0.5) causes π to drop from 0.984 to 0.549, which is an identity property; ③ Under spike-and-slab, π and difference scale are jointly non-identifiable; along the profile likelihood ridge, ΔlogL<2 covers π∈[0.10,0.75]; ④ Within the realistic band where π≥0.549, among 832 grid points only 51 can overturn the decision, all lying in z≥2.5; after removing this region, none of the 624 remaining points can overturn it; ⑤ Moving k from 0.25 to 10 expands π* by 13 times, giving decision-flipping power far exceeding that of π.
Partially Verified: ① Grid-point statistics rely on bilinear interpolation; the original table has only 6×4 nodes, so interpolation error is not quantified; ② The derivation of “π≥0.549” assumes differences follow a half-normal; under heavy tails (few extreme differences plus many tiny ones), the lower bound would shift downward; ③ Quantitative conversion uses k=1; when k≠1, numerical values need scaling, but qualitative conclusions remain unchanged; ④ The non-identifiability conclusion holds under normal slab; switching to heavy-tail slab distorts the ridge shape, and width may not narrow.
To Be Verified: ① No data exists on what magnitude π actually falls in real studies; all assertions here are theoretical lower bounds, not empirical findings; ② There is no standard specifying who should set the resolution and where, yet it directly determines π; ③ The appropriate value of k in the context of reading studies has never been discussed, yet this article proves it is far more important than π; ④ The claim that “π structure differs between methodology and clinical validation studies” cannot be tested with existing literature, because neither type reports π.
Further Reading
- The red line at ρ=0.5 does not mark danger, it marks gain
- The rule “over 10% means death” has never argued its 0.05
- “m≥0.95 means safe” is drawn from estimated numbers
- Resonance Consciousness Field Research Pool
Evidence Level: C
References: PMID 36123642, PMID 26810254, PMID 17099194, PMID 18177782, PMID 37399082, PMID 34062626, PMID 28626349, PMID 30383398, PMID 31730403, PMID 19538100, PMID 16483120
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply